Intra-ImmuSG seeks to develop a safer and more effective cancer therapy via a combination of a targeted therapy and immunotherapy.

Diagnosed with stage 3B lung cancer in 2018, I joined a support group where I met Jim and Melanie, and learned about Jim's ...

Despite hosting more oncology start-ups, Europe is lagging in the development of cancer technologies, losing the competitive ...

TUESDAY commemorates World Cancer Awareness Day. This year’s theme is United by Unique which is a patient-centric initiative ...

BRANFORD, Conn., Feb. 11, 2025 (GLOBE NEWSWIRE) -- EvolveImmune Therapeutics, an immunotherapy company developing first-in-category, multifunctional T Cell engager biotherapeutics to address unmet ...

Law professors and engineers take their bows, while a retired environmental scientist is the area’s top gardener.

Was it simply a fluke that he kept treating strikingly young patients? Or was his practice one tiny data point in a larger trend? He found his answer after sifting through national health data: ...

In a groundbreaking medical achievement in the U.K., a 32-year-old woman from Manchester has undergone the country's first ...

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

Bristol Myers Squibb on Thursday posted better-than-expected fourth quarter earnings, but said its 2025 revenue would fall ...